Clarius Group LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $701K | Sell |
28,141
-759
| -3% | -$19.1K | 0.04% | 160 |
|
|
2025
Q3 | $736K | Sell |
28,900
-11,762
| -29% | -$290K | 0.04% | 160 |
|
|
2025
Q2 | $986K | Buy |
40,662
+21,661
| +114% | +$505K | 0.06% | 148 |
|
|
2025
Q1 | $481K | Sell |
19,001
-11,746
| -38% | -$307K | 0.03% | 246 |
|
|
2024
Q4 | $816K | Buy |
30,747
+4,250
| +16% | +$115K | 0.06% | 140 |
|
|
2024
Q3 | $753K | Sell |
26,497
-2,200
| -8% | -$64.2K | 0.05% | 147 |
|
|
2024
Q2 | $803K | Sell |
28,697
-3,228
| -10% | -$88.9K | 0.06% | 146 |
|
|
2024
Q1 | $886K | Sell |
31,925
-4,310
| -12% | -$120K | 0.06% | 137 |
|
|
2023
Q4 | $1.04M | Sell |
36,235
-10,372
| -22% | -$314K | 0.09% | 120 |
|
|
2023
Q3 | $1.55M | Sell |
46,607
-10,675
| -19% | -$377K | 0.15% | 78 |
|
|
2023
Q2 | $2.1M | Sell |
57,282
-872
| -1% | -$33.9K | 0.16% | 70 |
|
|
2023
Q1 | $2.37M | Sell |
58,154
-4,565
| -7% | -$197K | 0.2% | 61 |
|
|
2022
Q4 | $3.21M | Buy |
62,719
+45
| +0.1% | +$2.16K | 0.29% | 50 |
|
|
2022
Q3 | $2.74M | Buy |
62,674
+5,559
| +10% | +$270K | 0.27% | 49 |
|
|
2022
Q2 | $3M | Buy |
57,115
+3,364
| +6% | +$171K | 0.3% | 43 |
|
|
2022
Q1 | $3.17M | Hold |
53,751
| – | – | 0.25% | 48 |
|
|
2021
Q4 | $3.17M | Buy |
53,751
+2,947
| +6% | +$146K | 0.25% | 48 |
|
|
2021
Q3 | $2.19M | Buy |
50,804
+1,037
| +2% | +$45.9K | 0.2% | 60 |
|
|
2021
Q2 | $1.95M | Buy |
49,767
+5,943
| +14% | +$231K | 0.17% | 67 |
|
|
2021
Q1 | $1.59M | Sell |
43,824
-7,230
| -14% | -$257K | 0.16% | 75 |
|
|
2020
Q4 | $1.88M | Buy |
51,054
+8,278
| +19% | +$304K | 0.2% | 55 |
|
|
2020
Q3 | $1.49M | Sell |
42,776
-469
| -1% | -$16.4K | 0.19% | 59 |
|
|
2020
Q2 | $1.34M | Buy |
43,245
+1,457
| +3% | +$49.5K | 0.19% | 65 |
|
|
2020
Q1 | $1.29M | Buy |
41,788
+2,822
| +7% | +$96.2K | 0.24% | 54 |
|
|
2019
Q4 | $1.5M | Buy |
38,966
+222
| +0.6% | +$7.91K | 0.24% | 58 |
|
|
2019
Q3 | $1.32M | Buy |
38,744
+9,429
| +32% | +$343K | 0.24% | 61 |
|
|
2019
Q2 | $1.21M | Sell |
29,315
-3,116
| -10% | -$124K | 0.24% | 58 |
|
|
2019
Q1 | $1.31M | Buy |
32,431
+13,787
| +74% | +$552K | 0.32% | 50 |
|
|
2018
Q4 | $772K | Buy |
18,644
+4,747
| +34% | +$197K | 0.28% | 45 |
|
|
2018
Q3 | $581K | Buy |
+13,897
| New | +$535K | 0.21% | 53 |
|
|
2017
Q3 | – | Sell |
-14,015
| Closed | -$447K | – | 92 |
|
|
2017
Q2 | $447K | Buy |
14,015
+236
| +2% | +$7.44K | 0.18% | 56 |
|
|
2017
Q1 | $447K | Sell |
13,779
-228
| -2% | -$7.19K | 0.18% | 55 |
|
|
2016
Q4 | $432K | Buy |
14,007
+502
| +4% | +$15.3K | 0.18% | 54 |
|
|
2016
Q3 | $434K | Sell |
13,505
-3,826
| -22% | -$128K | 0.2% | 54 |
|
|
2016
Q2 | $579K | Buy |
17,331
+3,270
| +23% | +$104K | 0.31% | 42 |
|
|
2016
Q1 | $395K | Sell |
14,061
-26
| -0.2% | -$743 | 0.22% | 54 |
|
|
2015
Q4 | $431K | Buy |
+14,087
| New | +$443K | 0.25% | 43 |
|
Other funds holding PFE
Clarius Group LLC's PFE Position: Q4 2025 in Review
Clarius Group LLC reduced its Pfizer (PFE) stake by 2.6% in Q4 2025, selling an estimated $19.1K and leaving 28,141 shares worth $701K. The position accounts for 0.04% of the portfolio, ranked #160.
Clarius Group LLC first reported a position in PFE in Q4 2015 and has held it in 37 quarters since. The position peaked at $3.21M in Q4 2022. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Clarius Group LLC held 28,141 shares of Pfizer worth $701K as of Q4 2025.
- Clarius Group LLC sold 759 Pfizer shares in Q4 2025, an estimated $19.1K.
- Pfizer made up 0.04% of Clarius Group LLC's portfolio in Q4 2025, its #160 holding.
- Clarius Group LLC first reported a position in Pfizer in Q4 2015 and has held it in 37 quarters since.
- Clarius Group LLC's Pfizer position peaked at $3.21M in Q4 2022.
- 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.